Company Therapeutics Programs Diagnostic Programs Research & Discovery Collaborations Investors
 
Compugen Discovers Novel Protein for Treatment of Autoimmune Diseases|Feb 02, 2010
Compugen Raises Gross Proceeds of $20 Million Through Sale of Ordinary Shares|Dec 30, 2009